BioNTech SE (BNTX) Other Non-Current Assets (2018 - 2025)
BioNTech SE's (BNTX) quarterly Other Non-Current Assets came in at $202.3 million in Q4 2025, down 10.99% year-on-year from $227.3 million in Q4 2024, and down 40.92% quarter-over-quarter from $342.4 million in Q3 2025.
BioNTech SE (BNTX) Other Non-Current Assets (2018 - 2025) Analysis & Trends
BioNTech SE has disclosed Other Non-Current Assets across 7 years of filings, most recently posting $202.3 million for Q4 2025.
- Other Non-Current Assets for Q4 2025 came in at $202.3 million, down 10.99% year-over-year; the trailing twelve-month figure through Dec 2025 was $202.3 million (down 10.99% YoY), and the FY2025 annual result was $196.4 million, down 13.61% from the prior year.
- Other Non-Current Assets came in at $202.3 million for Q4 2025 at BioNTech SE, down from $342.4 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $386.9 million in Q2 2024 to a low of $49.7 million in Q2 2022.
- The 5-year median for Other Non-Current Assets is $231.2 million (2023), against an average of $226.3 million.
- Across the five-year window, Other Non-Current Assets soared 364.92% in 2023 and slumped 37.1% in 2025, its largest moves.
- BioNTech SE's Other Non-Current Assets stood at $129.7 million in 2021, then climbed by 26.46% to $164.0 million in 2022, then jumped by 84.24% to $302.2 million in 2023, then retreated by 24.8% to $227.3 million in 2024, then slipped by 10.99% to $202.3 million in 2025.
- The last three Other Non-Current Assets figures came in at $202.3 million (Q4 2025), $342.4 million (Q3 2025), and $243.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | BioNTech SE | 27.31 Bn | 9.99 Bn | 668.28 Mn | 202.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 202.31 Mn |
| Sep 30, 2025 | 342.42 Mn |
| Jun 30, 2025 | 243.37 Mn |
| Mar 31, 2025 | 246.46 Mn |
| Dec 31, 2024 | 227.29 Mn |
| Sep 30, 2024 | 302.89 Mn |
| Jun 30, 2024 | 386.93 Mn |
| Mar 31, 2024 | 366.10 Mn |
| Dec 31, 2023 | 302.23 Mn |
| Sep 30, 2023 | 311.55 Mn |
| Jun 30, 2023 | 231.18 Mn |
| Mar 31, 2023 | 183.86 Mn |
| Sep 30, 2022 | 164.05 Mn |
| Jun 30, 2022 | 49.72 Mn |
| Mar 31, 2022 | 72.84 Mn |
| Dec 31, 2021 | 129.73 Mn |
| Mar 31, 2021 | 83.95 Mn |
| Dec 31, 2019 | 10.04 Mn |
| Sep 30, 2019 | 10.40 Mn |
| Dec 31, 2018 | 10.46 Mn |